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Brief Report
A papillary fibroelastoma of the tricuspid valve
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Abstract Primary cardiac tumours are rare in children. Of these, papillary fibroelastomas are unusual but
benign, usually being found in adults. There are only sporadic cases reported in children. We diagnosed such a
papillary fibroelastoma involving the tricuspid valve in an asymptomatic child during a routine cardiac
investigation.
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P
RIMARY CARDIAC TUMOURS ARE RARE IN
children, with Beghetti and colleagues1 reporting
an incidence of 0.32% in a total of 27,640
patients with cardiac disease. The diagnosis has
increased in the last decade due to the improvement
in non-invasive imaging techniques. Of these tumours,
papillary fibroelastomas are rare and benign, accounting
for less than one-tenth of all primary cardiac tumours,2
but still representing the commonest tumour afflicting
the cardiac valves.3 In children, however, there are only
sporadic reports. The patients are usually asympto-
matic, and the lesions are often diagnosed incidentally
in the process of cardiac investigation for an unrelated
problem, at necropsy, or during cardiac surgery.4 We
describe here an asymptomatic lesion involving the
tricuspid valve, discovered incidentally in the process of
cardiac investigation of an otherwise healthy child.
Case report
A 6-year-old asymptomatic boy was referred to our
department for diagnosis and treatment of a mass
involving the tricuspid valve. His past medical
history was not relevant. One year previously, an
echocardiographic evaluation had been performed
because of discovery of a heart murmur during a
routine examination. The investigation disclosed a
dysplastic tricuspid valve, with redundant localized
thick tissue, albeit in an otherwise normal heart. A
repeat echocardiogram performed one year after the
first revealed an echo dense tumour arising from the
septal leaflet of the valve, with moderate tricuspid
regurgitation.
On examination, he had a soft pansystolic heart
murmur, graded at 2 from 6, and best heard at the
third and fourth left intercostals space at the sternal
border.
For a more accurate assessment, we performed
a transoesophageal echocardiogram, which revealed
a very mobile mass with multiple papillary fronds,
18 millimetres in diameter, attached by a stalk
to the atrial aspect of the tricuspid valve and
projecting into the right outflow tract. The study
confirmed the presence of moderate tricuspid valvar
regurgitation (Fig. 1).
Because of its mobility, and the risk of
embolisation, the mass was surgically removed.
Histopathologic examination provided the diagnosis
of papillary fibroelastoma (Fig. 2). The postopera-
tive recovery was uneventful, and after six months of
follow up, the child remains asymptomatic, with no
recurrence of the tumour.
Discussion
Cardiac tumours are rare at all ages, and are even
less common in infants and children. Cardiac
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papillary fibroelastomas are the least frequent of all
benign cardiac tumours found in childhood. These
tumours, however, occur at all ages, albeit being
more frequent in adults, particularly between the
5th and 8th decades of life. Their pathogenesis
remains unclear, although several possible expla-
nations have been proposed, such as previous
mechanical damage to the endothelium, an unusual
endocardial response to infection or haemodynamic
trauma, hamartomatous origin, or organized embo-
lisation. There is evidence that iatrogenic factors,
such as previous cardiac surgery, could play a role in
their development.5
The majority of the cases present as solitary
masses, but there are examples of multiple
tumours reported in the literature.6 The surface of
the valvar leaflets is the predominant location of
this tumour, usually on the left side of the heart,
involving the aortic valve in just under half the
cases, the mitral in one third, the tricuspid valve
in one-sixth, and the pulmonary valve in less than
one-tenth.7 The atrial endocardial aspect is most
frequently when the papillary fibroelastomas
arise from the atrioventricular valves. When the
arterial valves are involved, both sides of the leaflets
can be affected. Nonvalvar sites of attachment have
also been reported, most frequently in the left
ventricle.
Morphologically, papillary fibroelastomas resem-
ble a sea anemone when viewed under a saline
solution, with multiple papillary fronds attached
to a short pedicle of dense connective tissue covered
by hyperplastic endothelial cells. They can measure
from 0.1 to 3 centimeters in diameter, reaching a
maximum of 5 centimeters. Patients with this
type of tumour can present in several ways. In
the majority of cases, the tumours are found
incidentally during the process of cardiac investiga-
tion for an unrelated problem, or else they are
discovered at necropsy. It is well recognised that
cardiac tumours are great mimics of other forms of
cardiac disease. The most common clinical pre-
sentation is an embolic event to the cerebral,
systemic, or coronary arterial circulations. Some
patients present in cardiac failure, while others
have died suddenly. Embolisation may occur from
the fragile papillary fronds, or some times these
tumours may provide a nidus for aggregation of
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Figure 1.
The transoesophageal echocardiography revealed a very mobile mass
of multiple papillary fronds, arranged on a stalk: Abbreviations
AO: aorta; arrow-tricuspid mass; RA: right atrium; RV: right
ventricle.
Figure 2.
The tricuspid tumour was confirmed at surgery (a) to be composed
of the multiple papillary fronds, and immersion is saline (b)
revealed its resemblance to a sea anemone.
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platelets and fibrin, which leads to subsequent
embolisation.8 Recently, a case was reported with
symptomatic thrombocytopenia, which improved
after removal of the tumour. At present, conven-
tional transthoracic echocardiography and transoe-
sophageal echocardiography are the gold standard
for diagnosis. Transthoracic echocardiography is a
useful tool for initial evaluation, but transoesopha-
geal echocardiography is frequently required for a
more comprehensive and accurate assessment, its
better resolution permitting location of the central
collagenous core of the tumour, and distinguish-
ing it from the rest of the mass by its bright
echocardiographic appearance. If clearly identified,
this central echo dense contrast should allow
differentiation of this tumour from other intracar-
diac masses, especially myxomas, but also vegeta-
tions, mural thrombus, valvar calcifications, and
Lambl’s excrescences.
Surgical treatment depends on the size, location,
mobility, and potential or strength of association of
the tumour with symptoms. Surgery is indicated for
isolated right-sided lesion only when they are large
and mobile, including those that result in obstruc-
tion or embolisation. The presence of a patent oval
foramen with a sizeable right-to-left shunt is an
additional consideration for surgical removal of
right-sided lesions. Surgery is also indicated for
left-sided lesions when they are bigger than 1
centimeter in size and are mobile. Conservative
treatment should be reserved for asymptomatic
patients with small non-mobile tumours. Although
recurrence after surgical excision is at yet unknown,
careful follow-up is warranted.9,10
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